General Range
FORAXIME 200
Price on request/100 · MOQ 100 boxes
FORAXIME 200 Dispersible Tablets by Fortune Labs contain Cefixime 200 mg and Lactic Acid Bacillus, a combination formulated for treating susceptible bacterial infections while providing probiotic support. Cefixime is a third-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis, helping eliminate infection-causing bacteria. Lactic Acid Bacillus is included to support intestinal microbial balance during antibiotic treatment, although its benefits depend on the formulation. FORAXIME 200 may be prescribed for selected respiratory tract infections, urinary tract infections, and typhoid fever when clinically appropriate. Available in 10 × 10 tablet blister packaging, this product is part of Fortune Labs' pharmaceutical range. Contact Fortune Labs for PCD Pharma Franchise opportunities, wholesale pricing, product availability, and distribution enquiries across India. Use only as prescribed.
CategoryGeneral Range
Min. Order100 boxes
Supplied byFortune Labs
CertificationWHO-GMP, ISO
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Specifications
- Composition
- Cefixime 200 mg + Lactic Acid Bacillus
- Packaging Type
- Blister Pack
- Packaging Size
- 10 × 10
- Dosage Form
- Tablet
- Treatment
- Bacterial respiratory tract infections, throat infections, urinary tract infections, typhoid fever, and other infections caused by susceptible bacteri
- Shelf Life
- 24 Months
- Storage
- Store below 30°C, protect from light & moisture
- Certification
- WHO-GMP, ISO
Company Info
Fortune LabsPanchkula, Haryana
Fortune Labs is an Indian pharmaceutical and PCD (Propaganda Cum Distribution) pharma franchise company based in Panchkula, Haryana.
Key Details
• Headquarters: S.C.F 258, 1st Floor, Sector 16, Panchkula, Haryana, India
• Establishment: Founded in 2008 (sister concern of Prosperity 6 Pharmaceutics in Baddi)
• CEO / Leadership: Mayank Bansal
• Certifications: ISO 9001, WHO-GMP, and DCGI-approved formulations
• Business Model: Offers Pan-India PCD pharma franchises with monopoly rights, third-party manufacturing, and marketing support.
Product Portfolio & Therapeutic Ranges
• Formulations: Tablets, capsules, syrups, dry powders, injectables, ointments, gels, eye/ear/nasal drops, softgel capsules, and Ayurvedic/herbal products.
• Therapeutic Segments: Antibiotics, cardiac and diabetic care, orthopedics, dermatology, gynaecology, paediatrics, gastrointestinal/PPI ranges, neurology, antihistamines/cough-cold, and nutritional supplements.
Would you like information on how to apply for a franchise partnership or specific product price lists from Fortune Labs?
More General Range
